What an incredible session at the AI in GxP Conference in Raleigh!

CenPharma President Diane Gates took the stage to discuss how AI is transforming deviation management and the evolving role of Quality, from initiation and investigation through CAPA development, trending, and ultimately better decision-making.

And judging by the packed room and the conversation that followed, this is a topic our industry is VERY ready to talk about.

AI isn’t about replacing Quality expertise. It’s about giving experienced Quality professionals better tools, helping identify patterns, reduce administrative burden, accelerate investigations, and allow our teams to spend more time applying the judgment and critical thinking that actually protect patients and products.

We’re incredibly proud to have Diane representing CenPharma and helping move that conversation forward.